Table 2. Patient demographics by country income grouping.

	AHOD	TAHOD	TAHOD
	(n = 945)	High Income	Low Income
		(n = 1260)	(n = 2045)
Sex	N (%)	N (%)	N (%)
Male	891 (94)	951 (75)	1434 (70)
Female	54 (4)	309 (25)	611 (30)
Age at ART initiation (Years)
less than 30	121 (13)	273 (22)	590 (29)
30 to 50	646 (68)	829 (66)	1313 (64)
greater than 50	178 (19)	158 (13)	142 (7)
mean	41.1	38.1	35.1
median (interquartile range)	40.3 (33.4–47.5)	36.2 (30.9–43.4)	33.8 (29.1–39.5)
AIDS
None	793 (84)	511 (41)	709 (35)
Yes	152 (16)	749 (59)	1336 (65)
AIDS illness pre-ART	50 (33)	173 (23)	343 (26)
AIDS illness post-ART	102 (67)	576 (77)	993 (74)
Exposure
Homosexual	644 (68)	392 (31)	151 (7)
Heterosexual	120 (13)	736 (58)	1345 (66)
IDU	50 (5)	34 (3)	319 (16)
Other	131 (14)	98 (8)	230 (11)
HBV
Negative	721 (76)	884 (70)	1202 (59)
Positive	36 (4)	175 (14)	134 (7)
Not Tested	188 (20)	201 (16)	709 (35)
HCV
Negative	737 (78)	887 (70)	769 (38)
Positive	80 (8)	78 (6)	384 (19)
Not Tested	128 (14)	295 (23)	892 (44)
CD4 cell count at ART initiation *
mean (cells/µL)	305	150	128
median (interquartile range)	271 (159–400)	125 (34–227)	110 (38–199)
Log RNA at ART initiation *
mean (copies/ml)	4.85	4.7	4.96
median (interquartile range)	4.96 (4.44–5.35)	4.73 (4.15–5.30)	5.0 (4.56–5.57)
Year ART Initiation
1996 to 2004	499 (53)	728 (58)	507 (25)
2005 to 2011	446 (47)	532 (42)	1538 (75)
Time followed on ART
mean (years)	5.3	5.1	3.1
median (interquartile range)	3.8 (1.8–8.8)	5.5 (2.9–7.5)	2.4 (0.9–5.1)
CD4 measurements (per year per person)
mean	3.4	1.9	1.7
median (interquartile range)	3 (2–4)	2 (1–2)	1 (1–2)
RNA measurements (per year per person)
Mean	3.3	1.4	0.6
median (interquartile range)	3 (2–4)	1 (1–2)	0 (0–1)

^*Closest record to ART initiation within a window of 6 month prior to ART and 1 week following ART initiation.